Global Inositol Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Inositol Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Inositol, also known as cyclohexanol, is naturally occurring. It exists in beans, fruits, bran, corn husks and other plants. The human body can also synthesize inositol by itself. Inositol is widely distributed in animals and plants and is a growth factor for animals and microorganisms. Inositol is an essential substance for the growth of humans, animals and microorganisms, and is widely used in feed, medicine, food and other industries. Inositol can prevent depression, lower cholesterol, fight fatty liver, strengthen bones, and lower blood sugar. Since inositol is non-toxic and harmless, it can be used in various health foods or oral liquids.

Market Overview:

The latest research study on the global Inositol market finds that the global Inositol market reached a value of USD 137.15 million in 2022. It’s expected that the market will achieve USD 126.23 million by 2028, exhibiting a CAGR of -1.37% during the forecast period.

The raging COVID-19 has plunged the global economic environment into depression. The impact of COVID-19 on the inositol industry will involve all entities in the industry chain. The company management efficiency has fallen, commuting has been severely hampered, production plans have been severely hampered, marketing has been delayed, market sales have fallen, and company and employee income has fallen. The government has also put forward higher requirements for the production and operation of inositol enterprises.

China is the main production and export region of inositol. Since China is also the initial outbreak area of COVID-19, they have severely affected the production and export of inositol. Due to the coronavirus crisis, transportation has also stopped, so sales are facing greater pressure. The global inositol supply cycle may be extended. At the same time, the uncertainty of the global epidemic will further strengthen the control measures of various countries, and the operating efficiency of affiliated companies is much worse than in the past.

The existence of outdated production processes leads to differences in the quality of inositol products on the market

Japan's patented technology for inositol production is characterized by simplified procedures, fewer workers, reduced production costs, and high inositol yield. The product does not go through the crude product stage, and directly produces high-quality products, and the quality can reach the United States Pharmacopoeia standard. Japan's inositol production technology level is higher than that of Chinese companies, and the raw material utilization rate of inositol in Japanese companies is above 85%.

However, in China, due to the low technical threshold for the production of inositol, the raw materials are readily available and inexpensive, and there are many manufacturers producing inositol, and most of the products are exported. At the same time, its production technology is relatively backward and raw material utilization rate is low.

Policy permission and wide application in the industry

The policy allows inositol to be added to food. At the same time, inositol is an essential substance for the growth of humans, animals and microorganisms, and is widely used in feed, medicine, food and other industries. Due to the nutritional effects of inositol, downstream application industries will need more inositol products. Therefore, inositol has huge market potential in the future. Manufacturers are trying to improve technology to produce high purity and high performance inositol.

Region Overview:

In global comparison, a significant portion of the revenue was generated in China (58.36% in 2021).

Company Overview:

Zhucheng Haotian Pharm is one of the major players operating in the Inositol market, holding a share of 18.3% in 2021.

Zhucheng Haotian Pharm

Zhucheng Haotian Pharm was founded in 1999. Its main products include stevia, inositol, baicalin, inositol nicotinate, valsartan, tricalcium phosphate, etc. Zhucheng Haotian Pharm is a producer and supplier of natural plant raw materials.

TSUNO

TSUNO is mainly engaged in:
Efficient use of rice bran
Manufacture, sales and research and development of rice oil
Production, sales and research and development of pharmaceutical raw materials, cosmetic raw materials and food additives made from rice bran
Production, sales and research and development of industrial greases,
Waste cooking oil recycling
Manufacturing, sales and research and development of food and feed additives

Segmentation Overview:

By type, Food Grade Inositolsegment accounted for the largest share of market in 2021.

Feed Grade Inositol

Feed grade inositol is an essential nutrient for certain animals and plays an important role in maintaining its normal physiological functions.

Food Grade Inositol

Food grade inositol can promote cell growth, participate in metabolism activities in the body, synthesize creatine phospholipids, membrane phospholipids, sphingomyelin, and other substances. It is a nutrient necessary to maintain the physiological functions of animals

Pharmaceutical Grade Inositol

Pharmaceutical grade inositol can promote fat metabolism in the liver, and is used to treat cirrhosis, fatty liver, hepatitis and other diseases. Pharmaceutical grade inositol also has the effect of lowering blood cholesterol levels, and can treat fat and cholesterol catabolism disorders.

Application Overview:

The market's largest segment by application is the segment Food & Beverages, with a market share of 42.88% in 2021.

Key Companies in the global Inositol market covered in Chapter 3:

Suning Yuwei
Zhucheng Haotian Pharm
Shijiazhuang Jingkai
Falcon Wealth(Jilin)Limited
Shandong Haishun Biologicals
TSUNO

In Chapter 4 and Chapter 14.2, on the basis of types, the Inositol market from 2018 to 2029 is primarily split into:

Feed Grade Inositol
Food Grade Inositol
Pharmaceutical Grade Inositol

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Inositol market from 2018 to 2029 covers:

Cosmetic
Food & Beverages
Pharmaceuticals

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)